Amati-Bonneau Patrizia, Valentino Maria Lucia, Reynier Pascal, Gallardo Maria Esther, Bornstein Belén, Boissière Anne, Campos Yolanda, Rivera Henry, de la Aleja Jesús González, Carroccia Rosanna, Iommarini Luisa, Labauge Pierre, Figarella-Branger Dominique, Marcorelles Pascale, Furby Alain, Beauvais Katell, Letournel Franck, Liguori Rocco, La Morgia Chiara, Montagna Pasquale, Liguori Maria, Zanna Claudia, Rugolo Michela, Cossarizza Andrea, Wissinger Bernd, Verny Christophe, Schwarzenbacher Robert, Martín Miguel Angel, Arenas Joaquín, Ayuso Carmen, Garesse Rafael, Lenaers Guy, Bonneau Dominique, Carelli Valerio
Département de Biochimie et Génétique, Centre Hospitalier Universitaire d'Angers, Angers, France.
Brain. 2008 Feb;131(Pt 2):338-51. doi: 10.1093/brain/awm298. Epub 2007 Dec 24.
Mutations in OPA1, a dynamin-related GTPase involved in mitochondrial fusion, cristae organization and control of apoptosis, have been linked to non-syndromic optic neuropathy transmitted as an autosomal-dominant trait (DOA). We here report on eight patients from six independent families showing that mutations in the OPA1 gene can also be responsible for a syndromic form of DOA associated with sensorineural deafness, ataxia, axonal sensory-motor polyneuropathy, chronic progressive external ophthalmoplegia and mitochondrial myopathy with cytochrome c oxidase negative and Ragged Red Fibres. Most remarkably, we demonstrate that these patients all harboured multiple deletions of mitochondrial DNA (mtDNA) in their skeletal muscle, thus revealing an unrecognized role of the OPA1 protein in mtDNA stability. The five OPA1 mutations associated with these DOA 'plus' phenotypes were all mis-sense point mutations affecting highly conserved amino acid positions and the nuclear genes previously known to induce mtDNA multiple deletions such as POLG1, PEO1 (Twinkle) and SLC25A4 (ANT1) were ruled out. Our results show that certain OPA1 mutations exert a dominant negative effect responsible for multi-systemic disease, closely related to classical mitochondrial cytopathies, by a mechanism involving mtDNA instability.
OPA1是一种与发动蛋白相关的GTP酶,参与线粒体融合、嵴组织形成及细胞凋亡调控,OPA1基因突变与以常染色体显性遗传特征传递的非综合征性视神经病变(DOA)相关。我们在此报告来自6个独立家庭的8例患者,结果显示OPA1基因突变也可能导致一种伴有感音神经性耳聋、共济失调、轴索性感觉运动性多发性神经病、慢性进行性外眼肌麻痹以及细胞色素c氧化酶阴性和破碎红纤维的线粒体肌病的综合征性DOA。最值得注意的是,我们证明这些患者骨骼肌中均存在线粒体DNA(mtDNA)的多重缺失,从而揭示了OPA1蛋白在mtDNA稳定性方面未被认识到的作用。与这些DOA“加”表型相关的5个OPA1突变均为错义点突变,影响高度保守的氨基酸位置,且排除了先前已知可诱导mtDNA多重缺失的核基因,如POLG1、PEO1(Twinkle)和SLC25A4(ANT1)。我们的结果表明,某些OPA1突变通过涉及mtDNA不稳定的机制发挥显性负效应,导致与经典线粒体细胞病密切相关的多系统疾病。